key: cord-1002474-2scczsyj
authors: Hendren, Nicholas S.; de Lemos, James A.; Grodin, Justin L.
title: Response by Hendren et al to Letter Regarding Article, “Association of Body Mass Index and Age With Morbidity and Mortality in Patients Hospitalized With COVID-19: Results From the American Heart Association COVID-19 Cardiovascular Disease Registry”
date: 2021-07-07
journal: Circulation
DOI: 10.1161/circulationaha.121.054556
sha: 5e58e24e9685dee2d83ac3438dc5dcfc7a7d916e
doc_id: 1002474
cord_uid: 2scczsyj

nan

We read with interest the letter by Yuping Li and Guangyu Lu in which they query whether an obesity paradox may exist for coronavirus disease 2019 (COVID-19). As the letter writers note, the obesity paradox has been described for several acute and chronic cardiovascular and pulmonary conditions, whereas overweight or mildly obese individuals may paradoxically have fewer adverse outcomes compared with individuals of normal weight. 1 To date, however, an obesity paradox for hospitalization, risk for mechanical ventilation, and all-cause death has not been observed in COVID-19. [2] [3] [4] The 2 largest studies have observed a greater dose-dependent risk for mechanical ventilation with increasing body mass index despite adjustment for patient risk factors. 3, 4 Likewise, a recent Centers for Disease Control study observed a greater dose-dependent risk of all-cause death in class I, II, or III obese individuals compared with either normal or overweight World Health Organization obesity classes. 4 Accordingly, the relationship of body weight to risk for severe COVID-19 may be distinct from previously described populations for which the obesity paradox has been described. The relatively low rate of cardiovascular complications likely reflects the overall short follow-up period (index hospitalization), the high competing risk of death, and the practical challenges of diagnosing an acute stroke, heart failure, or myocardial infarction in the setting of an acute lung injury or critical illness.

Because of the rapid acute lung injury in COVID-19, the direct association of body weight with adverse respiratory mechanics and cytokine production may increase the risk for mechanical ventilation, irrespective of baseline body fitness. 5 Although it is plausible that high cardiorespiratory fitness may mitigate some of the hazards of obesity in patients with COVID-19, we cannot address this question because fitness was not captured in our dataset. Additionally, "obese but fit" likely represent a small proportion of the world's obese population. In our cohort, overweight and obese individuals hospitalized with COVID-19 had a high comorbid disease burden of diabetes, hypertension, and previous cardiovascular disease representative of an obese and unfit population. 3 We believe the most prudent approach is to recognize that all obese individuals are at high risk for severe COVID-19 regardless of fitness and to encourage physical activity, weight loss, and COVID-19 vaccination. 

Intensive blood pressure control and body size

Obesity and mortality among patients diagnosed with COVID-19: results from an integrated health care organization

Association of body mass index and age with morbidity and mortality in patients hospitalized with CO-VID-19: results from the American Heart Association COVID-19 Car-Circulation is available at www.ahajournals.org/journal/circ diovascular Disease Registry

Body mass index and risk for COVID-19-related hospitalization, intensive care unit admission, invasive mechanical ventilation, and death -United States

The effect of obesity on lung function